Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents

Mathew P Leese; Fabrice Jourdan; E Ferrandis; S Regis-Lydi; P G Kasprzyk; C Stengel; S P Newman; A Purohit; M J Reed; Barry V L Potter

doi:10.1016/S1359-6349(10)72153-4

Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents

Mathew P Leese, Fabrice Jourdan, E Ferrandis, S Regis-Lydi, P G Kasprzyk, C Stengel, S P Newman, A Purohit, M J Reed, Barry V L Potter

Department of Life Sciences

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	141-141
Number of pages	1
Journal	EJC Supplements
Volume	8
Issue number	7
DOIs	https://doi.org/10.1016/S1359-6349(10)72153-4
Publication status	Published - Nov 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1359-6349(10)72153-4

Cite this

@article{612c84f297d545618f3c19c4982c29b1,

title = "Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents",

author = "Leese, {Mathew P} and Fabrice Jourdan and E Ferrandis and S Regis-Lydi and Kasprzyk, {P G} and C Stengel and Newman, {S P} and A Purohit and Reed, {M J} and Potter, {Barry V L}",

note = "Meeting abstract from 22nd EORTC NCI AACR Symposium on Molecular Targets and Cancer Therapeutics. 16-19 November 2010. Berlin, Germany.",

year = "2010",

month = nov,

doi = "10.1016/S1359-6349(10)72153-4",

language = "English",

volume = "8",

pages = "141--141",

journal = "EJC Supplements",

issn = "1359-6349",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents

AU - Leese, Mathew P

AU - Jourdan, Fabrice

AU - Ferrandis, E

AU - Regis-Lydi, S

AU - Kasprzyk, P G

AU - Stengel, C

AU - Newman, S P

AU - Purohit, A

AU - Reed, M J

AU - Potter, Barry V L

N1 - Meeting abstract from 22nd EORTC NCI AACR Symposium on Molecular Targets and Cancer Therapeutics. 16-19 November 2010. Berlin, Germany.

PY - 2010/11

Y1 - 2010/11

UR - http://dx.doi.org/10.1016/S1359-6349(10)72153-4

U2 - 10.1016/S1359-6349(10)72153-4

DO - 10.1016/S1359-6349(10)72153-4

M3 - Article

VL - 8

SP - 141

EP - 141

JO - EJC Supplements

JF - EJC Supplements

SN - 1359-6349

IS - 7

ER -

Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents

UN SDGs

Access to Document

Other files and links

Cite this